Compare Medtronic PLC (MDT) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs State Street SPDR S&P Homebuilders ETF — how do they compare? Medtronic PLC trades at $83.21 (market cap $106.61B), while State Street SPDR S&P Homebuilders ETF trades at $106.54. The key difference: Medtronic PLC pays a 3.46% dividend while State Street SPDR S&P Homebuilders ETF pays none, and State Street SPDR S&P Homebuilders ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | XHB | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $105.35 | $121.36 |
52-Week Low | $73.75 | $94.86 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
XHB trades at $106.07, down 2.01% today amid a bearish technical signal with moving averages indicating selling pressure. The ETF faces mixed housing data, with June home sales declining but new legislation potentially boosting homebuilders. Key support lies at $104, while resistance is at $110. Financial ratios are unavailable, but sentiment is influenced by macroeconomic factors like mortgage rates and housing affordability.
Outlook remains cautious due to high mortgage rates and volatile home sales, though regulatory support offers upside potential. Risks include interest rate sensitivity and economic slowdowns. Investors should weigh technical weakness against long-term housing demand drivers for balanced exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
